Stephen Parker
Président chez BIODEXA PHARMACEUTICALS PLC
Fortune : 65 341 $ au 30/06/2024
Profil
Stephen B.
Parker is the founder of UK Stem Cell Foundation.
He currently holds multiple positions, including Executive Chairman at Sareum Holdings Plc, Non-Executive Chairman at Biodexa Pharmaceuticals Plc, Chairman at Drishti Discoveries Ltd., Director at Sareum Ltd., Director at Sp2 Consulting Ltd., Non-Executive Director at Eternans Ltd., and Director at Sp2 Asset Management Ltd.
Previously, he served as Non-Executive Chairman at Argent BioPharma Ltd., Non-Executive Chairman at Physiomics Plc, Chairman at Liverpool Chirochem Ltd., and Independent Non-Executive Director at Silence Therapeutics Plc.
He has also held positions as Partner at Celtic Pharma Management LP, Director at Xenova Group Plc, Director at GCA Altium Ltd., Director at Celtic Pharma Development UK Plc, Director at Novacta Biosystems Ltd., Director at PBB Devices Ltd., Director at Xenova Ltd., Non-Executive Director at Gammadelta Therapeutics Ltd., Director at Albucasis Ltd., Director at Celtic Pharma GP Ltd., Principal at Apax Partners LLP, Principal at Celtic Pharma Holdings Advisors LLP, Consultant at Pa Consulting Group Ltd., Principal at Warburg Group Plc, Chief Financial Officer at Oxford GlycoSciences Plc, Principal at Barings Plc, Partner at Beehive Capital LLP, and Head-Partner Network, Research & Development at Bedford Royalties Ltd.
He holds a doctorate degree from the University of Oxford, an undergraduate degree from the University of East Anglia, and an MBA from Bayes Business School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
SAREUM HOLDINGS PLC
0,11% | 28/03/2024 | 116 158 ( 0,11% ) | 65 341 $ | 30/06/2024 |
Postes actifs de Stephen Parker
| Sociétés | Poste | Début |
|---|---|---|
| BIODEXA PHARMACEUTICALS PLC | Président | 20/06/2022 |
| SAREUM HOLDINGS PLC | Président | 17/05/2016 |
| Sp2 Consulting Ltd. | Directeur/Membre du Conseil | - |
| Eternans Ltd. | Directeur/Membre du Conseil | 01/07/2019 |
Drishti Discoveries Ltd.
 Drishti Discoveries Ltd. BiotechnologyHealth Technology Drishti Discoveries Ltd. is a British company founded in 2019 that aims to develop a gene therapy that provides a long-term knockdown of target gene expression. Drishti Discoveries is based in Cambridge, UK. The company uses technology to achieve this goal. The company's website uses cookies to improve user experience while navigating through the website. The website also uses third-party cookies to analyze and understand how users interact with the website. Necessary cookies are used to ensure basic functionalities and security features of the website. Functional cookies are used to perform certain functionalities like sharing the content of the website on social media platforms, collect feedback, and other third-party features. | Président | 01/01/2021 |
Sareum Ltd.
 Sareum Ltd. Drugstore ChainsRetail Trade Sareum Ltd. provides drug discovery services for treatment of cancer. The company develops robust pipeline of novel small molecule cancer drug candidates for partnering with pharmaceutical companies. Sareum is headquartered in Cambridge, UK | Directeur/Membre du Conseil | - |
| Sp2 Asset Management Ltd. | Directeur/Membre du Conseil | 01/09/2018 |
Celtic Pharma Management LP
 Celtic Pharma Management LP Investment ManagersFinance Celtic Pharma Management LP is a private equity firm founded by Stephen Evans Freke and John Mayo in 2004. The firm headquartered in Bermuda. | Private Equity Investor | 01/04/2005 |
Anciens postes connus de Stephen Parker
| Sociétés | Poste | Fin |
|---|---|---|
| ARGENT BIOPHARMA LIMITED | Président | 01/12/2023 |
| ░░░░░░░ ░░░░░░░░░░░░ ░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Stephen Parker
| University of Oxford | Doctorate Degree |
| Bayes Business School | Masters Business Admin |
| University of East Anglia | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 5 |
|---|---|
| PHYSIOMICS PLC | Commercial Services |
| SILENCE THERAPEUTICS PLC | Commercial Services |
| BIODEXA PHARMACEUTICALS PLC | Health Technology |
| ARGENT BIOPHARMA LIMITED | Health Technology |
| SAREUM HOLDINGS PLC | Miscellaneous |
| Entreprise privées | 25 |
|---|---|
Xenova Group Plc
 Xenova Group Plc Miscellaneous Commercial ServicesCommercial Services Xenova Group Plc researches and develops pharmaceutical products. The company is focused on the development of novel drugs to treat cancer and addiction with a secondary focus in immunotherapy. It has pipeline of drug candidates in clinical development including a novel program for the treatment of high-grade glioma and TransMID. The company was founded in 1987 and is headquartered in Slough, UK | Commercial Services |
| UK Stem Cell Foundation | Miscellaneous |
Novacta Biosystems Ltd.
 Novacta Biosystems Ltd. BiotechnologyHealth Technology Novacta Biosystems Ltd. discovered and developed drugs for treatment of bacterial infections. Its products included lantibiotic/bacteriocin variants, as well as a development candidate for the treatment of C. difficile infection. The company was founded by John Michael Dawson on February 14, 2015 and was headquartered in London, the United Kingdom. | Health Technology |
Celtic Pharma Management LP
Celtic Pharma Management LP Investment ManagersFinance Celtic Pharma Management LP is a private equity firm founded by Stephen Evans Freke and John Mayo in 2004. The firm headquartered in Bermuda. | Finance |
Celtic Pharma Holdings Advisors LLP
 Celtic Pharma Holdings Advisors LLP Investment ManagersFinance Celtic Pharma Holdings Advisors LLP operates as an alternative investment manager. The company was founded on April 16, 2008 and is headquartered in London, the United Kingdom. | Finance |
Apax Partners LLP
 Apax Partners LLP Investment ManagersFinance Apax Partners LLP engages in providing investment services. It focuses on investing in firms across the global sectors such as technology and telecommunications, services, healthcare, and consumer. The company was founded by Ronald Mourad Cohen and Alan J. Patricof in 1969 and is headquartered in London, the United Kingdom. | Finance |
| Warburg Group Plc | Finance |
Barings Plc
 Barings Plc Regional BanksFinance The Barings group collapsed in February 1995 as a direct result of unauthorised trading conducted on the Singapore International Monetary Exchange by Nick Leeson, the general manager of Barings Futures (Singapore) Ltd (BFS). The frauds were perpetrated through an account numbered 88888 and resulted in losses amounting to £791 million. The Barings group had funded these losses, in ignorance of the real use to which the funds were being put. It was BFS' inability to repay its debts to the other group companies that brought down the group. | Finance |
Beehive Capital LLP
 Beehive Capital LLP Investment ManagersFinance Beehive Capital LLP (Beehive Capital) is a private equity firm founded in 2002. The firm is headquartered in London, United Kingdom. | Finance |
PA Consulting Group Ltd.
 PA Consulting Group Ltd. Miscellaneous Commercial ServicesCommercial Services PA Consulting Group Ltd. engages in the provision of management, systems, technology consulting, and innovation services. The company was founded by Ernest Button on September 3, 2015 and is headquartered in London, the United Kingdom. | Commercial Services |
Bedford Royalties Ltd.
 Bedford Royalties Ltd. Pharmaceuticals: MajorHealth Technology Bedford Royalties Ltd. used to provide pharmaceutical services. The company was founded on August 26, 2011 and was headquartered in Reading, the United Kingdom. | Health Technology |
GCA Altium Ltd.
 GCA Altium Ltd. Investment Banks/BrokersFinance Part of Houlihan Lokey, Inc., GCA Altium Ltd. is a brokerage services provider. The company is based in London, UK. The British company was founded by Michael James Hough. Philip Adams has been the CEO of the company since 1996. GCA Altium was acquired by GCA Corp. (Japan), part of Houlihan Lokey, Inc. from September 27, 2021 on July 31, 2016 for $110.25 million. | Finance |
Oxford GlycoSciences Plc
 Oxford GlycoSciences Plc Pharmaceuticals: MajorHealth Technology Oxford Glycosciences Plc provides biopharmaceutical products. The company develops and manufactures novel products for the diagnosis and treatment of human disease. Its products include bayer, pioneer hi-breddupont, medarex, genmab, glaxosmithkline, neogenesis and pfizer. It was founded in 1988. The company is headquartered in Abingdon, UK. | Health Technology |
Celtic Pharma Development UK Plc
 Celtic Pharma Development UK Plc Financial ConglomeratesFinance Celtic Pharma Development UK Plc provides financial management services. The company was founded in 2005 and is located in London, GB | Finance |
Ah Animal Healthcare Ltd.
 Ah Animal Healthcare Ltd. BiotechnologyHealth Technology Ah Animal Healthcare Ltd. develops biosuperior protein therapeutics. The company’s services include biopharmaceutical discovery, process development and GMP manufacturing. It focuses on particular characteristics of biologic drugs that include product presentation and stability, pharmacokinetics, pharmacodynamics, immunogenicity and drug delivery. The company was founded in 1989 and is headquartered in Reading, the United Kingdom. | Health Technology |
| Sp2 Asset Management Ltd. | |
| Xenova Ltd. | |
Sareum Ltd.
Sareum Ltd. Drugstore ChainsRetail Trade Sareum Ltd. provides drug discovery services for treatment of cancer. The company develops robust pipeline of novel small molecule cancer drug candidates for partnering with pharmaceutical companies. Sareum is headquartered in Cambridge, UK | Retail Trade |
Drishti Discoveries Ltd.
Drishti Discoveries Ltd. BiotechnologyHealth Technology Drishti Discoveries Ltd. is a British company founded in 2019 that aims to develop a gene therapy that provides a long-term knockdown of target gene expression. Drishti Discoveries is based in Cambridge, UK. The company uses technology to achieve this goal. The company's website uses cookies to improve user experience while navigating through the website. The website also uses third-party cookies to analyze and understand how users interact with the website. Necessary cookies are used to ensure basic functionalities and security features of the website. Functional cookies are used to perform certain functionalities like sharing the content of the website on social media platforms, collect feedback, and other third-party features. | Health Technology |
PBB Devices Ltd.
 PBB Devices Ltd. Medical SpecialtiesHealth Technology PBB Devices Ltd. is engaged in the commercialization of scientific research into optoelectronics and the provision of legal manufacturer services. The firm offers products for various applications, such as general practitioner and physician offices and routine assessment of diabetic complications. The company was founded by Jody Brown, Vincent Peter Crabtree and Peter Smith on September 25, 2002 and is headquartered in Reading, the United Kingdom. | Health Technology |
| Eternans Ltd. | |
Liverpool Chirochem Ltd.
 Liverpool Chirochem Ltd. BiotechnologyHealth Technology Liverpool Chirochem Ltd. Produces and supply small organic molecules for biotech and pharmaceutical research and development. The firm offers building blocks, screening libraries and chemistry services. The company was founded by Jianjun Wu and Paul Colbon is headquartered in Liverpool, the United Kingdom. | Health Technology |
Gammadelta Therapeutics Ltd.
 Gammadelta Therapeutics Ltd. BiotechnologyHealth Technology Gammadelta Therapeutics Ltd. is developing the potential of gamma delta (?d) cells to create improved immunotherapy of cancer and other serious diseases. The company was founded by Raj Mehta in 2016 and is headquartered in London, the United Kingdom. | Health Technology |
| Sp2 Consulting Ltd. | |
| Celtic Pharma GP Ltd. |
